REQUEST A DEMO
Total
USD $0.00
Search more companies

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Medical Equipment and Supplies Manufacturing
Full name: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Profile Updated: March 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a leading publicly listed company in the pharmaceutical industry in China. The company focuses on the modern biopharmaceutical and healthcare industry. It strategically covers multiple important aspects of the pharmaceutical and healthcare industry chain, including research and development, manufacturing, distribution, and end-users. The company has a core focus on drug research and manufacturing and holds a leading market position in areas such as pharmaceutical distribution, medical services, medical diagnostics, and medical devices. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has established a competitive advantage in research and development innovation, market marketing, mergers and acquisitions, and talent development. The company emphasizes innovation and research and has a national-level enterprise technology center. It has also established efficient international research and development teams in Shanghai, Chongqing, and the United States. The company's research and development efforts focus on treatment areas such as metabolism and the digestive system, cardiovascular, anti-tumor and immune regulation, the nervous system, and anti-infection. Its main products hold leading positions in their respective sub-markets. In China, the company has a competitive advantage in sub-markets such as liver disease, diabetes, tuberculosis, and clinical diagnostic products. In the global market, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a leader in anti-malarial drugs. While focusing on developing its core pharmaceutical business, the company actively expands into the medical services field and further strengthens its competitive advantage in medical diagnostics and medical devices. The company has established a solid foundation in the high-end and specialized medical services sector in China.

Headquarters
9F 510 Caoyong Rd. Shanghai
Shanghai; Shanghai; Postal Code: 200233

Contact Details: Purchase the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report to view the information.

Website: http://www.fosunpharma.com

Basic Information
Total Employees:
Purchase the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report to view the information.
Registered Capital:
Purchase the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report to view the information.
Incorporation Date:
July 13, 1998
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive President
Purchase this report to view the information.
Executive President
Ownership Details
Purchase this report to view the information.
33.16%
Purchase this report to view the information.
20.63%
Purchase this report to view the information.
1.45%
Purchase this report to view the information.
1.38%
Purchase this report to view the information.
0.93%
Subsidiaries
Chindex Medical Limited
100%
Fosun Industrial (Hong Kong) Co., Ltd.
100%
Jiangsu Wanbang Biochemical and Pharmaceutical Group Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Shanghai Fosun Pharmaceutical (Group) Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-2.92%
Total operating revenue
2.88%
Operating profit (EBIT)
-6.14%
EBITDA
0.69%
Net Profit (Loss) for the Period
-3.83%
Total assets
6.17%
Total equity
5.18%
Operating Profit Margin (ROS)
-0.37%
Net Profit Margin
-0.09%
Return on Equity (ROE)
-0.44%
Debt to Equity Ratio
4.25%
Quick Ratio
-0.11%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?